Bariatric Surgery and GLP-1 Drugs Both Support Sustained Fat Loss
Although bariatric surgery was associated with more evident changes, research found that treatment with glucagon-like peptide-1 (GLP-1) medications was also associated with sustained fat loss in a clinical setting.
FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications
The US Food and Drug Administration (FDA) requested that drug application holders remove suicidal ideation and behavior warnings from glucagon-like peptide-1 (GLP-1) receptor agonists.
IJMS, Vol. 27, Pages 1409: Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes
IJMS, Vol. 27, Pages 1409: Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes International Journal of Molecular Sciences doi: 10.3390/ijms27031409 Authors: Urna Kansakar Stanislovas S. Jankauskas Shivangi Pande Pasquale Mone Fahimeh Varzideh Gaetano Santulli Orforglipron (LY3502970) is a novel, orally available, nonpeptide glucagon-like peptide-1 receptor agonist […]
Heart Failure Data Added to GLP-1 Prescribing Info
Mounjaro significantly reduced hospitalizations in adults with obesity and symptomatic chronic heart failure with preserved ejection fraction. Medscape News Europe
GLP-1 Weight Loss Drugs and the ‘Exploding Colon’ Lawsuits: A Symptom of a Deeper Health Crisis
(NaturalNews) IntroductionA seismic shift in American health culture is being violently undone in courtrooms across the nation. The blockbuster GLP-1 weight-loss …
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space?
Post Content
STAT+: AstraZeneca looks to China for obesity drug candidates
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Oh, hi. Today, we discuss delays in the launch of TrumpRx. Also, Sanofi is deprioritizing its mRNA flu vaccine. The need-to-know this morning Regeneron Pharmaceuticals expects an FDA approval decision in the first half […]
The rise of ‘agonorexia’: People are developing brand new eating disorders on GLP-1 agonist drugs
“No one says, ‘Here’s your GLP-1, by the way, you might get an eating disorder.’”
Alert as health watchdog warns patients weight loss jabs can trigger life-threatening side effect: ‘It’s important to know the symptoms’
Health chiefs have warned that GLP-1 medication increases risk of developing severe inflammation of the pancreas – which can be fatal.
‘My Colon Literally Blew Up’: Thousands Sue Over GLP-1 Weight Loss Drug Side Effects
‘My Colon Literally Blew Up’: Thousands Sue Over GLP-1 Weight Loss Drug Side Effects A growing wave of lawsuits is challenging the safety warnings accompanying blockbuster weight-loss drugs that have rapidly reshaped American medicine and culture, raising questions about whether patients were adequately informed of the risks tied to medications now used by tens of […]